Sun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports
Read More
The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product
Read More
Capping the price of a device is counter-productive - it will halt research and innovation and won't benefit the patient; the cost of the device such as stent is a mere fraction of the total cost of the procedure required for its implantation
Read More
In a partnership that will look to address the need of the hour, Tata Trusts will invest its strategic knowhow in the realm of healthcare in the state
Read More
Big industry names participating in the BW Healthcare Summit were unanimous in their view that the country held huge untapped opportunities for healthcare services
Read More
Estimated to be valued at $2.5 trillion per year by 2025, IoT will change the accessibility and reach of healthcare services
Read More
Experts say India needs more financial investments and professional expertise to expand healthcare facilities across the country
Read More
Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year
Read More
